EUVIMEDEUVIMED entdecken
Open Access

Novel triazolo[1,5]benzodiazepines as potent dual AChE/BChE inhibitors for Alzheimer's disease: synthesis, characterization, in vitro and in silico studies

Marouane Ait Lahcen, Halil Şenol, Saad Zekri, Nastaran Sadeghian, Samir Hmaimou, Laura Chelazzi, Samuele Ciattini, Elena Zaballos-García, Parham Taslimi iD, Ismail Hdoufane, Driss Cherqaoui, Abdesselam Baouid und 1 weitere

RSC Medicinal Chemistry · 2026

DOI: 10.1039/d6md00416d ↗

Kurz gefasst

Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2026. Verfasst von Marouane Ait Lahcen und 12 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Sciences Semlalia, Molecular Chemistry Laboratory, Department of Chemistry, UCA, Cadi Ayyad University PB 2390 Marrakech 40001 Morocco m.a…. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Targeting Alzheimer's disease, a cycloaddition route furnishes triazolo[1,5]benzodiazepines with potent, picomolar dual AChE/BChE inhibition, validated by X-ray, NMR, HRMS, and molecular docking.

Autor:innen und Institutionen

  • Faculty of Sciences Semlalia, Molecular Chemistry Laboratory, Department of Chemistry, UCA, Cadi Ayyad University PB 2390 Marrakech 40001 Morocco m.adardour@uca.ac.ma.
  • Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Bezmialem Vakif University 34093 Fatih İstanbul Türkiye.
  • Department of Biotechnology, Faculty of Science, Bartin University 74110 Bartin Türkiye ptaslimi@bartin.edu.tr.
  • Centro di Cristallografia, University of Florence Via della Lastruccia 3, I-50019 Sesto Fiorentino Florence Italy.
  • Departamento de Quimica Organica, Facultad de Farmacia, Universidad de Valencia Ave. Vte. Andres Estelles s/n46100 Valencia Spain.

ORCID-Profile: Parham Taslimi, Mohamed Adardour

Zitieren

APA

Ait Lahcen, M., Şenol, H., Zekri, S., Sadeghian, N., Hmaimou, S., Chelazzi, L., Ciattini, S., Zaballos-García, E., Taslimi, P., Hdoufane, I., Cherqaoui, D., Baouid, A., & Adardour, M. (2026). Novel triazolo[1,5]benzodiazepines as potent dual AChE/BChE inhibitors for Alzheimer's disease: synthesis, characterization, in vitro and in silico studies. RSC Medicinal Chemistry. https://doi.org/10.1039/d6md00416d

Vancouver

Ait Lahcen M, Şenol H, Zekri S, Sadeghian N, Hmaimou S, Chelazzi L, et al. Novel triazolo[1,5]benzodiazepines as potent dual AChE/BChE inhibitors for Alzheimer's disease: synthesis, characterization, in vitro and in silico studies. RSC Medicinal Chemistry. 2026. doi:10.1039/d6md00416d

BibTeX
@article{AitLahcen2026,
  author = {Ait Lahcen, Marouane and Şenol, Halil and Zekri, Saad and Sadeghian, Nastaran and Hmaimou, Samir and Chelazzi, Laura and Ciattini, Samuele and Zaballos-García, Elena and Taslimi, Parham and Hdoufane, Ismail and Cherqaoui, Driss and Baouid, Abdesselam and Adardour, Mohamed},
  title = {Novel triazolo[1,5]benzodiazepines as potent dual AChE/BChE inhibitors for Alzheimer's disease: synthesis, characterization, in vitro and in silico studies},
  journal = {RSC Medicinal Chemistry},
  year = {2026},
  doi = {10.1039/d6md00416d}
}
Infokarte | EUVIMED

Artikeldaten derzeit nicht verfügbar.

Recherche